Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boezio

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 19, 2012
Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitorsChristiane M Bode, Alessandro A Boezio, Brian K Albrecht, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptorStephanie K Springer, Katrina S Woodin, Virginia Berry, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Discovery and optimization of substituted piperidines as potent, selective, CNS-penetrant alpha4beta2 nicotinic acetylcholine receptor potentiatorsBrian K Albrecht, Virginia Berry, Alessandro A Boezio, et al.
The Astrophysical Journal|May 17, 2000
First Mass-resolved Measurement of High-Energy Cosmic-Ray AntiprotonsBergström, Boezio, Carlson, et al.
Journal of Medicinal Chemistry|February 11, 2012
Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone seriesLongbin Liu, Mark H Norman, Matthew Lee, et al.
Journal of Medicinal Chemistry|March 5, 2016
Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo ActivityLaurie B Schenkel, Philip R Olivieri, Alessandro A Boezio, et al.
Journal of Medicinal Chemistry|April 9, 2026
Nanoscale Direct-to-Biology Optimization of Cdk2 InhibitorsJames L Douthwaite, Damian J Houde, Eneida Pardo, et al.
Journal of Medicinal Chemistry|March 22, 2017
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo ActivityRussell F Graceffa, Alessandro A Boezio, Jessica Able, et al.
Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)|February 13, 2003
Study of the radiation environment on MIR space station with SILEYE-2 experimentM Casolino, V Bidoli, E De Grandis, et al.
Pain|February 20, 2010
Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent painBaoXi Gao, Markus Hierl, Kristie Clarkin, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|May 19, 2012
Discovery and optimization of a potent and selective triazolopyridinone series of c-Met inhibitorsChristiane M Bode, Alessandro A Boezio, Brian K Albrecht, et al.
Bioorganic & Medicinal Chemistry Letters|September 23, 2008
Synthesis and activity of substituted carbamates as potentiators of the alpha4beta2 nicotinic acetylcholine receptorStephanie K Springer, Katrina S Woodin, Virginia Berry, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2008
Discovery and optimization of substituted piperidines as potent, selective, CNS-penetrant alpha4beta2 nicotinic acetylcholine receptor potentiatorsBrian K Albrecht, Virginia Berry, Alessandro A Boezio, et al.
The Astrophysical Journal|May 17, 2000
First Mass-resolved Measurement of High-Energy Cosmic-Ray AntiprotonsBergström, Boezio, Carlson, et al.
Journal of Medicinal Chemistry|February 11, 2012
Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone seriesLongbin Liu, Mark H Norman, Matthew Lee, et al.
Journal of Medicinal Chemistry|March 5, 2016
Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo ActivityLaurie B Schenkel, Philip R Olivieri, Alessandro A Boezio, et al.
Journal of Medicinal Chemistry|April 9, 2026
Nanoscale Direct-to-Biology Optimization of Cdk2 InhibitorsJames L Douthwaite, Damian J Houde, Eneida Pardo, et al.
Journal of Medicinal Chemistry|March 22, 2017
Sulfonamides as Selective Na<sub>V</sub>1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo ActivityRussell F Graceffa, Alessandro A Boezio, Jessica Able, et al.
Advances in Space Research : the Official Journal of the Committee on Space Research (COSPAR)|February 13, 2003
Study of the radiation environment on MIR space station with SILEYE-2 experimentM Casolino, V Bidoli, E De Grandis, et al.
Pain|February 20, 2010
Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent painBaoXi Gao, Markus Hierl, Kristie Clarkin, et al.
Pageof 7